Genetic epidemiology of primary sclerosing cholangitis

被引:52
|
作者
Karlsen, Tom H. [1 ]
Schrumpf, Erik [1 ]
Boberg, Kirsten Muri [1 ]
机构
[1] Univ Oslo, Rikshosp, Radiumhosp Med Ctr, Dept Med, N-0027 Oslo, Norway
关键词
primary sclerosing cholangitis; genetic associations; human leukocyte antigens; cholangiocarcinoma; inflammatory bowel disease;
D O I
10.3748/wjg.v13.i41.5421
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aetiology of primary sclerosing cholangitis (PSC) is not known. A more than 80-fold increased risk of PSC among first-degree relatives emphasizes the importance of genetic factors. Genetic associations within the human leukocyte antigen (HLA) complex on chromosome 6p21 were detected in PSC 25 years ago. Subsequent studies have substantiated beyond doubt that one or more genetic variants located within this genetic region are important. The true identities of these variants, however, remain to be identified. Several candidate genes at other chromosomal loci have also been investigated. However, according to strict criteria for what may be denominated a susceptibility gene in complex diseases, no such gene exists for PSC today. This review summarises present knowledge on the genetic susceptibility to PSC, as well as genetic associations with disease progression and clinical subsets of particular interest (inflammatory bowel disease and cholangiocareinoma).
引用
收藏
页码:5421 / 5431
页数:11
相关论文
共 50 条
  • [31] Recent Advances in the Management of Primary Sclerosing Cholangitis
    Assis, David N.
    Bowlus, Christopher L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (08) : 2065 - 2075
  • [32] Pathogenesis and clinical spectrum of primary sclerosing cholangitis
    Neelam G Gidwaney
    Swati Pawa
    Kiron M Das
    World Journal of Gastroenterology, 2017, (14) : 2459 - 2469
  • [33] Pathogenesis and clinical spectrum of primary sclerosing cholangitis
    Gidwaney, Neelam G.
    Pawa, Swati
    Das, Kiron M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (14) : 2459 - 2469
  • [34] Screening for Malignancy in Primary Sclerosing Cholangitis (PSC)
    Khaderi S.A.
    Sussman N.L.
    Current Gastroenterology Reports, 2015, 17 (4)
  • [35] Diagnosis and therapeutic problems of primary sclerosing cholangitis
    Colle, I
    Van Vlierberghe, H
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2003, 66 (02): : 155 - 159
  • [36] New Therapeutic Strategies for Primary Sclerosing Cholangitis
    Williamson, Kate D.
    Chapman, Roger W.
    SEMINARS IN LIVER DISEASE, 2016, 36 (01) : 5 - 14
  • [37] Advances in primary sclerosing cholangitis
    Horsley-Silva, Jennifer L.
    Carey, Elizabeth J.
    Lindor, Keith D.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (01): : 68 - 77
  • [38] Cholangiocarcinoma in primary sclerosing cholangitis
    Abbas G.
    Lindor K.D.
    Journal of Gastrointestinal Cancer, 2009, 40 (1-2) : 19 - 25
  • [39] The immunobiology of primary sclerosing cholangitis
    Aron, Jonathan H.
    Bowlus, Christopher L.
    SEMINARS IN IMMUNOPATHOLOGY, 2009, 31 (03) : 383 - 397
  • [40] An update on primary sclerosing cholangitis
    Maggs, James R. L.
    Chapman, Roger W.
    CURRENT OPINION IN GASTROENTEROLOGY, 2008, 24 (03) : 377 - 383